Private Equity
Andrea Alms Video: Money In Motion 100 - Cancer Market Wrap-Up
March 2024 - Private Equity
TRANSCRIPT
Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion On our cancer series. We uncovered various cancer segment sizes and growth rates. Now let's review and find out which is the top market segment. Please note we did not include surgery or hormone replacement due to lack of good cancer data and high fragmentation and later episodes.
We may look at those distinct markets. Now let's review. As you may recall, averaging the averages, the overall global cancer market is 238.8 billion U.S. dollars. With a cop out average growth rate of 9.5%. As for the bone marrow transplantation market, the average market size is 10.7 billion, with a growth rate of 4.5%. The average market size of chemotherapy market is 19.6 billion, at 8.9% growth rate.
The antigen drug conjugate average market size is 8.1 billion at 12.4%. The radiation therapy market size is 7.7 billion at 5.9%. Average compound average growth rate. Lastly, the immunotherapy market size is 131.8 billion at 12.1% growth rate in the category of largest market size by U.S. dollar amount. First place goes to monotherapy at $131.8 billion. Market size in a distant second place is chemotherapy, then bone marrow transplant, education, drug conjugate and radiation therapy in the category of growth rate.
First place goes to antigen drug conjugate and a close second place goes to immunotherapy, both first and second place posting double digit growth rate. My pick is the immunotherapy market with triple digit market size U.S. dollars and growing at double digit growth rate. Thank you. This is your money, your money, in motion.